MAPT and Alzheimer disease: Studies reported that high cholesterol might influence the β-/γ-secretase activity, leading to Aβ generation from APP, reduce the flux of APP via the non-amyloidogenic pathway, and affect several non-amyloid factors such as tau metabolism or local inflammation, which are correlated to AD pathogenesis (Gamba et al., 2019).